NasdaqGM - Delayed Quote USD

InterCure Ltd. (INCR)

2.6600 +0.0100 (+0.38%)
At close: April 26 at 4:00 PM EDT
2.5550 -0.10 (-3.95%)
After hours: April 26 at 6:19 PM EDT
Key Events
Loading Chart for INCR
DELL
  • Previous Close 2.6500
  • Open 2.6300
  • Bid --
  • Ask --
  • Day's Range 2.6300 - 2.7000
  • 52 Week Range 0.9900 - 2.9200
  • Volume 11,853
  • Avg. Volume 84,844
  • Market Cap (intraday) 121.223M
  • Beta (5Y Monthly) 0.24
  • PE Ratio (TTM) 22.17
  • EPS (TTM) 0.1200
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 33.99

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

www.intercure.co

370

Full Time Employees

December 31

Fiscal Year Ends

Recent News: INCR

Performance Overview: INCR

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

INCR
106.20%
S&P 500
6.92%

1-Year Return

INCR
16.16%
S&P 500
25.26%

3-Year Return

INCR
66.46%
S&P 500
22.00%

5-Year Return

INCR
14.19%
S&P 500
74.29%

Compare To: INCR

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: INCR

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    121.22M

  • Enterprise Value

    137.09M

  • Trailing P/E

    21.86

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.11

  • Price/Book (mrq)

    0.90

  • Enterprise Value/Revenue

    0.33

  • Enterprise Value/EBITDA

    5.31

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.04%

  • Return on Assets (ttm)

    1.12%

  • Return on Equity (ttm)

    3.38%

  • Revenue (ttm)

    414.79M

  • Net Income Avi to Common (ttm)

    20.9M

  • Diluted EPS (ttm)

    0.1200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    102.84M

  • Total Debt/Equity (mrq)

    30.86%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: INCR

Analyst Price Targets

33.99
33.99 Average
2.6600 Current
33.99 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: INCR

Fair Value

2.6600 Current
 

Dividend Score

0 Low
INCR
Sector Avg.
100 High
 

Hiring Score

0 Low
INCR
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
INCR
Sector Avg.
100 High
 

People Also Watch